share_log

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director George Simeon

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director George Simeon

CRISPR Therapeutics | 4：持股变动声明-董事 George Simeon
美股SEC公告 ·  05/31 16:54
Moomoo AI 已提取核心信息
In a recent transaction, George Simeon engaged with CRISPR Therapeutics AG, trading under the symbol CRSP, on May 30, 2024. The details of the transaction, including the number of shares involved and the nature of the transaction, have not been disclosed. As of now, the relationship of George Simeon to the issuer remains unspecified. Investors are advised to note the date of the transaction for their records.
In a recent transaction, George Simeon engaged with CRISPR Therapeutics AG, trading under the symbol CRSP, on May 30, 2024. The details of the transaction, including the number of shares involved and the nature of the transaction, have not been disclosed. As of now, the relationship of George Simeon to the issuer remains unspecified. Investors are advised to note the date of the transaction for their records.
在最近的一笔交易中，乔治·西蒙于2024年5月30日与CRISPR Therapeutics AG进行了交易，股票代码为CRSP。该交易的细节，包括所涉及的股票数量和交易的性质，尚未披露。截至目前，乔治·西蒙与发行人的关系仍未明确。建议投资者记下交易日期以备记录。
在最近的一笔交易中，乔治·西蒙于2024年5月30日与CRISPR Therapeutics AG进行了交易，股票代码为CRSP。该交易的细节，包括所涉及的股票数量和交易的性质，尚未披露。截至目前，乔治·西蒙与发行人的关系仍未明确。建议投资者记下交易日期以备记录。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息